Production of a humanized Ah receptor mouse line

人源化Ah受体小鼠系的生产

基本信息

  • 批准号:
    9207268
  • 负责人:
  • 金额:
    $ 7.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-03-01 至 2019-02-28
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract The physiological function of the aryl hydrocarbon receptor (AHR) is an area of keen interest, especially in terms of its role in gut homeostasis, microbiome composition, and immune regulation. In addition, absence of AHR expression in the gastrointestinal tract leads to increased susceptibility to an adverse challenge, such as citrobacter rodentium exposure. Perhaps this is due in part to the central role that the AHR plays in Il-22 expression within the gut. We have published a number of articles identifying endogenous or microbiome generated AHR ligands, many of which have been discovered to be dramatically more potent activators of the human AHR compared to mouse AHR. These studies have lead to the central hypothesis that the human AHR plays an increased role in gut homeostasis compared to the mouse AHR. In order to test this hypothesis, we need to develop a suitable humanized AHR mouse. Thus, the specific aim is to generate a knock-in mouse that expresses the human Ah receptor. The actual hypothesis would be addressed in a subsequent grant application. The mouse line will be generated by Cyagen; a company with extensive experience with generating knock-in mice. The key aspect of our approach is the use of a codon optimized and secondary RNA structure disrupted synthetic human AHR cDNA, which exhibits a 4-fold higher level of expression than wild-type human AHR cDNA. The knock-in human AHR mouse line will be characterized to establish that it exhibits a similar level and pattern of AHR expression relative to a C57BL/6J mouse. In addition, the level of induction of AHR target genes is appropriate for the ligand specificity of the human AHR previously established. This humanized AHR mouse will be useful for a wide range of studies of the role of the AHR in disease processes, as well as assessing the human AHR as a therapeutic target.
项目总结/摘要 芳香烃受体(AHR)的生理功能是一个非常感兴趣的领域,特别是在 就其在肠道稳态、微生物组组成和免疫调节中的作用而言。此外,缺乏 胃肠道中的AHR表达导致对不利挑战的易感性增加,例如 啮齿类柠檬酸杆菌暴露。也许这部分是由于AHR在伊尔-22中扮演的核心角色 肠道内的表达。我们已经发表了一些文章,确定内源性或微生物组 产生的AHR配体,其中许多已被发现是显着更有效的激活剂, 人AHR与小鼠AHR的比较。这些研究导致了一个中心假设,即人类 与小鼠AHR相比,AHR在肠道稳态中发挥更大的作用。为了测试这种 假设,我们需要开发合适的人源化AHR小鼠。因此,具体目标是生成一个 表达人Ah受体的基因敲入小鼠。实际的假设将在 随后的补助金申请。小鼠品系将由Cyagen生产,该公司拥有广泛的 基因敲入小鼠的经验。我们的方法的关键方面是使用密码子优化, 二级RNA结构被破坏的合成人AHR cDNA,其表现出4倍高的水平, 与野生型人AHR cDNA相比,将对敲入的人AHR小鼠系进行表征, 确定其表现出与C57 BL/6 J小鼠相似的AHR表达水平和模式。在 此外,AHR靶基因的诱导水平适合于人AHR的配体特异性。 以前建立的。这种人源化的AHR小鼠将可用于广泛的研究AHR的作用。 疾病过程中的AHR,以及评估人类AHR作为治疗靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gary H. Perdew其他文献

The Janus-facedness of the aryl hydrocarbon receptor pathway Report of the 6th International AHR Meeting: Research, Prevention, Therapy
芳烃受体通路的两面性——第六届国际芳烃受体会议报告:研究、预防、治疗
  • DOI:
    10.1016/j.bcp.2025.116808
  • 发表时间:
    2025-04-01
  • 期刊:
  • 影响因子:
    5.600
  • 作者:
    Thomas Haarmann-Stemmann;Doreen Reichert;Xavier Coumoul;B.Paige Lawrence;Gary H. Perdew;David H. Sherr;Heike Weighardt;Katharina M. Rolfes;Charlotte Esser
  • 通讯作者:
    Charlotte Esser
Molecular networking identifies an AHR-modulating benzothiazole from white button mushrooms (emAgaricus bisporus/em)
分子网络鉴定出一种来自白蘑菇(双孢蘑菇)的 AHR 调节苯并噻唑
  • DOI:
    10.1016/j.jff.2023.105602
  • 发表时间:
    2023-07-01
  • 期刊:
  • 影响因子:
    4.000
  • 作者:
    Xiaoling Chen;Andrew D. Patterson;Gary H. Perdew;Iain A. Murray;Joshua J. Kellogg
  • 通讯作者:
    Joshua J. Kellogg

Gary H. Perdew的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gary H. Perdew', 18)}}的其他基金

Activation of the Ah receptor and epithelial integrity
Ah 受体的激活和上皮完整性
  • 批准号:
    10408032
  • 财政年份:
    2017
  • 资助金额:
    $ 7.86万
  • 项目类别:
Activation of the Ah receptor and epithelial integrity
Ah 受体的激活和上皮完整性
  • 批准号:
    10623257
  • 财政年份:
    2017
  • 资助金额:
    $ 7.86万
  • 项目类别:
Activation of the Ah receptor and epithelial integrity
Ah 受体的激活和上皮完整性
  • 批准号:
    10172905
  • 财政年份:
    2017
  • 资助金额:
    $ 7.86万
  • 项目类别:
Activation of the Ah receptor and epithelial integrity
Ah 受体的激活和上皮完整性
  • 批准号:
    9565593
  • 财政年份:
    2017
  • 资助金额:
    $ 7.86万
  • 项目类别:
Selective Ah Receptor Ligands Repress Acute-Phase Response
选择性 Ah 受体配体抑制急性期反应
  • 批准号:
    8659594
  • 财政年份:
    2013
  • 资助金额:
    $ 7.86万
  • 项目类别:
Selective Ah Receptor Ligands Repress Acute-Phase Response
选择性 Ah 受体配体抑制急性期反应
  • 批准号:
    8232259
  • 财政年份:
    2012
  • 资助金额:
    $ 7.86万
  • 项目类别:
Selective Ah Receptor Ligands Repress Acute-Phase Response
选择性 Ah 受体配体抑制急性期反应
  • 批准号:
    8575541
  • 财政年份:
    2012
  • 资助金额:
    $ 7.86万
  • 项目类别:
Selective Ah Receptor Ligands Repress Acute-Phase Response
选择性 Ah 受体配体抑制急性期反应
  • 批准号:
    8411131
  • 财政年份:
    2012
  • 资助金额:
    $ 7.86万
  • 项目类别:
Selective Ah Receptor Ligands Repress Acute-Phase Response
选择性 Ah 受体配体抑制急性期反应
  • 批准号:
    8769150
  • 财政年份:
    2012
  • 资助金额:
    $ 7.86万
  • 项目类别:
Cloning of Ah receptor bound regulatory DNA
Ah 受体结合调节 DNA 的克隆
  • 批准号:
    6904566
  • 财政年份:
    2004
  • 资助金额:
    $ 7.86万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 7.86万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.86万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 7.86万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.86万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 7.86万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 7.86万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.86万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 7.86万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 7.86万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.86万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了